Trial Outcomes & Findings for Evaluation of the Effectiveness of Calcium Phosphate Containing Desensitizer on Postoperative Sensitivity (NCT NCT04540835)
NCT ID: NCT04540835
Last Updated: 2025-12-23
Results Overview
Postoperative hypersensitivity was evaluated using a 10-cm Visual Analogue Scale (VAS). The scale consisted of a straight 10-cm line with endpoints defining extreme limits: "no pain at all" (score = 0) and "pain as bad as it could be" (score = 10). Participants were asked to mark their perceived pain level on the line between the two endpoints. The distance (in cm) from the "no pain" end to the mark represented the participant's pain score. Higher scores indicated greater hypersensitivity (worse outcome).
COMPLETED
NA
50 participants
7 days after restoration
2025-12-23
Participant Flow
Unit of analysis: restorations
Participant milestones
| Measure |
All Study Participants
Since the study was designed as split-mouth, each participant had 2 restorations (experimental and control group) .
The study groups allocated according to randomisation list created in www.sealedenvelope.com
|
|---|---|
|
Week 1
STARTED
|
50 100
|
|
Week 1
Teethmate Desensitizer
|
49 49
|
|
Week 1
Negative Control
|
49 49
|
|
Week 1
COMPLETED
|
49 98
|
|
Week 1
NOT COMPLETED
|
1 2
|
|
Week 6
STARTED
|
49 98
|
|
Week 6
Teethmate Desensitizer
|
47 47
|
|
Week 6
Negative Control
|
47 47
|
|
Week 6
COMPLETED
|
47 94
|
|
Week 6
NOT COMPLETED
|
2 4
|
Reasons for withdrawal
| Measure |
All Study Participants
Since the study was designed as split-mouth, each participant had 2 restorations (experimental and control group) .
The study groups allocated according to randomisation list created in www.sealedenvelope.com
|
|---|---|
|
Week 1
Lost to Follow-up
|
1
|
|
Week 6
Pregnancy
|
1
|
|
Week 6
Lack of Efficacy
|
1
|
Baseline Characteristics
overall 50 participants enrolled
Baseline characteristics by cohort
| Measure |
Experimental (Teethmate) and Control Groups
n=100 teeth
Since the study was designed as split-mouth, all participants had both experimental and control groups .
|
|---|---|
|
Sex/Gender, Customized
All genders
|
50 participants
n=50 Participants • overall 50 participants enrolled
|
|
Age, Continuous
|
30 years
STANDARD_DEVIATION 12 • n=50 Participants
|
|
Preoperative Vitality Measurement
|
100 teeth
n=100 teeth
|
PRIMARY outcome
Timeframe: 7 days after restorationPostoperative hypersensitivity was evaluated using a 10-cm Visual Analogue Scale (VAS). The scale consisted of a straight 10-cm line with endpoints defining extreme limits: "no pain at all" (score = 0) and "pain as bad as it could be" (score = 10). Participants were asked to mark their perceived pain level on the line between the two endpoints. The distance (in cm) from the "no pain" end to the mark represented the participant's pain score. Higher scores indicated greater hypersensitivity (worse outcome).
Outcome measures
| Measure |
Teethmate
n=49 restorations
Half of the cavities will be applied Teethmate Desensitizer following manufacturer instructions before restoration
Teethmate Desensitizer (Kuraray): Calcium phosphate desensitizer applied after caries removal. After restored using an oblique incremental technique with a composite resin (Filtek Z250, 3M Espe, USA) POS after 6 weeks was reported in 34% of teeth of experimental group.
|
Negative Control
n=49 restorations
Half of the cavities will be restored without application of Teethmate Desensitizer.
POS after 6 weeks was reported in 40.4% of teeth of control group.
|
|---|---|---|
|
Visual Analog Scale (VAS)
|
0.4 cm on a 10-point Visual Analogue Scale
Standard Deviation 1.6
|
1.3 cm on a 10-point Visual Analogue Scale
Standard Deviation 5.1
|
PRIMARY outcome
Timeframe: 7 days after restorationProgress of postoperative hypersensitivity will be also evaluated by using Numerical Rating Scale with five possibilities for the patient to state how much sensitivity there is in each tooth. The patients will have the option of saying whether the sensitivity was equal to 0 (none), 1 (mild), 2 (moderate), 3 (considerable), or 4 (severe). The mean and standard deviation (SD) of NRS scores were calculated for each group.
Outcome measures
| Measure |
Teethmate
n=49 restorations
Half of the cavities will be applied Teethmate Desensitizer following manufacturer instructions before restoration
Teethmate Desensitizer (Kuraray): Calcium phosphate desensitizer applied after caries removal. After restored using an oblique incremental technique with a composite resin (Filtek Z250, 3M Espe, USA) POS after 6 weeks was reported in 34% of teeth of experimental group.
|
Negative Control
n=49 restorations
Half of the cavities will be restored without application of Teethmate Desensitizer.
POS after 6 weeks was reported in 40.4% of teeth of control group.
|
|---|---|---|
|
Numerical Rating Scale (NRS)
|
0.1 score on a scale
Standard Deviation 0.3
|
0.1 score on a scale
Standard Deviation 0.3
|
SECONDARY outcome
Timeframe: 6 weeks after restorationThis patient-reported outcome was pre-specified in the study protocol to assess the presence of postoperative hypersensitivity at 6 weeks.
Outcome measures
| Measure |
Teethmate
n=47 restorations
Half of the cavities will be applied Teethmate Desensitizer following manufacturer instructions before restoration
Teethmate Desensitizer (Kuraray): Calcium phosphate desensitizer applied after caries removal. After restored using an oblique incremental technique with a composite resin (Filtek Z250, 3M Espe, USA) POS after 6 weeks was reported in 34% of teeth of experimental group.
|
Negative Control
n=47 restorations
Half of the cavities will be restored without application of Teethmate Desensitizer.
POS after 6 weeks was reported in 40.4% of teeth of control group.
|
|---|---|---|
|
Presence of Postoperative Hypersensitivity (Patient-reported at 6 Weeks)
|
47 restorations
|
47 restorations
|
Adverse Events
All Participants
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place